Clinical trial NCT04736264 - References

Primary Open Angle Glaucoma — Malay Glaucoma Eye Study II Navigation, Mobility and Reading Ability in Primary Glaucoma

Citation(s)

•   Chong Seong NT, Yaakub A, Jalil RA, Tirmandas Vn K, A/P Sandragasu T, Noor JBM, Husain NB, Mustari ZB, Hamid SAA, Mt Saad AB, At LS
  Effect of physical activity on severity of primary angle closure glaucoma. Ther Adv Ophthalmol. 2019 Jul 29;11:25158414198
•   Friedman DS, Freeman E, Munoz B, Jampel HD, West SK
  Glaucoma and mobility performance: the Salisbury Eye Evaluation Project. Ophthalmology. 2007 Dec;114(12):2232-7. Epub 2007 Nov 5.
•   Izzotti A, Bagnis A, Saccà SC
  The role of oxidative stress in glaucoma. Mutat Res. 2006 Mar;612(2):105-14. Epub 2006 Jan 18. Review.
•   Majsterek I, Malinowska K, Stanczyk M, Kowalski M, Blaszczyk J, Kurowska AK, Kaminska A, Szaflik J, Szaflik JP
  Evaluation of oxidative stress markers in pathogenesis of primary open-angle glaucoma. Exp Mol Pathol. 2011 Apr;90(2):231-7. doi: 10.1016/j.yex
•   Markowitz M
  Occupational therapy interventions in low vision rehabilitation. Can J Ophthalmol. 2006 Jun;41(3):340-7. Review.
•   McKean-Cowdin R, Wang Y, Wu J, Azen SP, Varma R; Los Angeles Latino Eye Study Group
  Impact of visual field loss on health-related quality of life in glaucoma: the Los Angeles Latino Eye Study. Ophthalmology. 2008 Jun;115(6):941-948.e1. Epub 2007 Nov 12.
•   Nilsson UL
  Visual rehabilitation of patients with advanced stages of glaucoma, optic atrophy, myopia or retinitis pigmentosa. Doc Ophthalmol. 1988 Dec;70(4):363-83.
•   Ramulu P
  Glaucoma and disability: which tasks are affected, and at what stage of disease? Curr Opin Ophthalmol. 2009 Mar;20(2):92-8. doi: 10.1097/ICU.0b013e32832401a9. Review.
•   Ramulu PY, Maul E, Hochberg C, Chan ES, Ferrucci L, Friedman DS
  Real-world assessment of physical activity in glaucoma using an accelerometer. Ophthalmology. 2012 Jun;119(6):1159-66. doi: 10.1016/j.ophtha.2012.01.013. Epub 2012 Mar 2.
•   Ramulu PY, West SK, Munoz B, Jampel HD, Friedman DS
  Glaucoma and reading speed: the Salisbury Eye Evaluation project. Arch Ophthalmol. 2009 Jan;127(1):82-7. doi: 10.1001/archophthalmol.2008.523.
•   Saccà SC, Izzotti A, Rossi P, Traverso C
  Glaucomatous outflow pathway and oxidative stress. Exp Eye Res. 2007 Mar;84(3):389-99. Epub 2006 Dec 29. Review.
•   Salim S
  Oxidative stress and psychological disorders. Curr Neuropharmacol. 2014 Mar;12(2):140-7. doi: 10.2174/1570159X11666131120230309.
•   Stelmack JA, Tang XC, Wei Y, Wilcox DT, Morand T, Brahm K, Sayers S, Massof RW; LOVIT II Study Group
  Outcomes of the Veterans Affairs Low Vision Intervention Trial II (LOVIT II): A Randomized Clinical Trial. JAMA Ophthalmol. 2017 Feb 1;135(2):96-104. doi
•   Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY
  Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014 Nov;121(11):2081-90. doi: 10.1016/j.ophtha.2014.05.013. Epub 20
•   Turano KA, Rubin GS, Quigley HA
  Mobility performance in glaucoma. Invest Ophthalmol Vis Sci. 1999 Nov;40(12):2803-9.
•   van Landingham SW, Willis JR, Vitale S, Ramulu PY
  Visual field loss and accelerometer-measured physical activity in the United States. Ophthalmology. 2012 Dec;119(12):2486-92. doi: 10.1016/j.ophtha.2012.06.034. Epub 2012 Aug 11.
•   Viswanathan AC, McNaught AI, Poinoosawmy D, Fontana L, Crabb DP, Fitzke FW, Hitchings RA
  Severity and stability of glaucoma: patient perception compared with objective measurement. Arch Ophthalmol. 1999 Apr;117(4):450-4.
•   Weinreb RN, Aung T, Medeiros FA
  The pathophysiology and treatment of glaucoma: a review. JAMA. 2014 May 14;311(18):1901-11. doi: 10.1001/jama.2014.3192. Review.
•   Wilkinson ME, Shahid KS
  Low vision rehabilitation: An update. Saudi J Ophthalmol. 2018 Apr-Jun;32(2):134-138. doi: 10.1016/j.sjopt.2017.10.005. Epub 2017 Oct 27. Review.

Malay Glaucoma Eye Study II: Elucidating Navigation, Mobility and Reading Ability to Improve Quality of Life and Progression of Primary Glaucoma

Details for clinical trial NCT04736264